Vaccine escape in a heterogeneous population: insights for SARS-CoV-2 from a simple model
As a countermeasure to the SARS-CoV-2 pandemic, there has been swift development and clinical trial assessment of candidate vaccines, with subsequent deployment as part of mass vaccination campaigns. However, the SARS-CoV-2 virus has demonstrated the ability to mutate and develop variants, which can...
| Main Authors: | , , , |
|---|---|
| Format: | Journal article |
| Jezik: | English |
| Izdano: |
Royal Society
2021
|